.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKinsey
Federal Trade Commission
AstraZeneca
Farmers Insurance
Novartis
Argus Health
McKesson
Cantor Fitzgerald
Mallinckrodt

Generated: December 17, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019386

« Back to Dashboard

NDA 019386 describes BREVIBLOC IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and is included in one NDA. It is available from four suppliers. There are two patents protecting this drug. Additional details are available on the BREVIBLOC IN PLASTIC CONTAINER profile page.

The generic ingredient in BREVIBLOC IN PLASTIC CONTAINER is esmolol hydrochloride. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the esmolol hydrochloride profile page.

Summary for 019386

Tradename:3
Applicant:1
Ingredient:1
Patents:2
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 019386

Mechanism of ActionAdrenergic beta-Antagonists

Suppliers and Packaging for NDA: 019386

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BREVIBLOC esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA West Ward Pharmaceutical Corporation 0641-2965 0641-2965-45 25 VIAL in 1 BOX (0641-2965-45) > 10 mL in 1 VIAL (0641-2965-41)
BREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINER esmolol hydrochloride INJECTABLE;INJECTION 019386 NDA West Ward Pharmaceutical Corporation 0641-2965 0641-2965-45 25 VIAL in 1 BOX (0641-2965-45) > 10 mL in 1 VIAL (0641-2965-41)

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Aug 15, 1988TE:RLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1GM/100ML
Approval Date:Feb 16, 2001TE:RLD:Yes
Patent:► SubscribePatent Expiration:Jul 12, 2021Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Jul 12, 2021Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 019386

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter HlthcareBREVIBLOCesmolol hydrochlorideINJECTABLE;INJECTION019386-003Aug 15, 1988► Subscribe► Subscribe
Baxter HlthcareBREVIBLOC DOUBLE STRENGTH IN PLASTIC CONTAINEResmolol hydrochlorideINJECTABLE;INJECTION019386-005Jan 27, 2003► Subscribe► Subscribe
Baxter HlthcareBREVIBLOCesmolol hydrochlorideINJECTABLE;INJECTION019386-007May 28, 2003► Subscribe► Subscribe
Baxter HlthcareBREVIBLOCesmolol hydrochlorideINJECTABLE;INJECTION019386-006Feb 25, 2003► Subscribe► Subscribe
Baxter HlthcareBREVIBLOC IN PLASTIC CONTAINEResmolol hydrochlorideINJECTABLE;INJECTION019386-004Feb 16, 2001► Subscribe► Subscribe
Baxter HlthcareBREVIBLOCesmolol hydrochlorideINJECTABLE;INJECTION019386-003Aug 15, 1988► Subscribe► Subscribe
Baxter HlthcareBREVIBLOCesmolol hydrochlorideINJECTABLE;INJECTION019386-003Aug 15, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Healthtrust
Baxter
Mallinckrodt
US Department of Justice
Federal Trade Commission
US Army
Express Scripts
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot